Jojoba Company   Report issue

For profit
Founded: Sydney Australia (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2018
NCT03449303
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

The Jojoba Company

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 7